Eris Lifesciences Limited has informed the Exchange regarding 'Certificate under reg. 57(1) of SEBI LODR Reg., 2015'.
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has made its annual interest payment on two series of Non-Convertible Debentures on the scheduled due date of June 9, 2025. For ISIN INE406M08029 (issue size Rs. 625 crore), the company paid Rs. 54.56 crore gross (Rs. 53.80 crore net of TDS). For ISIN INE406M08011 (also Rs. 625 crore), it paid Rs. 54.56 crore gross (Rs. 54.01 crore net of TDS). Total gross interest serviced comes to about Rs. 109.12 crore. No redemption payment was due. The filing is a routine regulatory disclosure confirming on-time debt servicing with no delays or changes in payment frequency.
This is a routine compliance filing with no material impact on equity shareholders. It confirms that Eris Lifesciences is meeting its debt obligations on schedule, which is mildly positive for the company's credit profile but unlikely to move the stock price.